XML 43 R7.htm IDEA: XBRL DOCUMENT v3.2.0.727
Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)
$ in Millions
9 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Operating activities:    
Net income $ 626.3 $ 578.1
Adjustments to arrive at cash provided by operating activities:    
Depreciation 99.6 91.6
Amortization of intangible assets 21.3 22.8
Share-based compensation expense 31.4 32.1
Retirement benefit expense 106.4 100.0
Pension contributions (30.9) (32.7)
Net (gain) loss on disposition of property (1.0) 0.1
Income tax benefit from the exercise of stock options 0.0 0.1
Excess income tax benefit from share-based compensation (12.2) (29.1)
Changes in assets and liabilities, excluding effects of acquisitions and foreign currency adjustments:    
Receivables 60.7 15.1
Inventories (45.0) (42.3)
Accounts payable 53.4 31.4
Advance payments from customers and deferred revenue 26.2 25.5
Compensation and benefits (58.1) (21.3)
Income taxes (12.7) (29.1)
Other assets and liabilities (25.7) (34.9)
Cash provided by operating activities 839.7 707.4
Investing activities:    
Capital expenditures (83.2) (96.4)
Acquisition of businesses, net of cash acquired (21.2) (81.5)
Purchases of short-term investments (470.8) (487.0)
Proceeds from maturities of short-term investments 501.8 285.3
Proceeds from sale of property 2.0 0.3
Other investing activities 0.0 (3.4)
Cash used for investing activities (71.4) (382.7)
Financing activities:    
Net (repayment) issuance of short-term debt (325.0) 100.9
Issuance of long-term debt, net of discount and issuance costs 594.3 0.0
Cash dividends (263.3) (240.9)
Purchases of treasury stock (404.8) (345.2)
Proceeds from the exercise of stock options 55.5 104.7
Excess income tax benefit from share-based compensation 12.2 29.1
Other financing activities (1.6) 0.0
Cash used for financing activities (332.7) (351.4)
Effect of exchange rate changes on cash (59.7) 0.9
Increase (decrease) in cash and cash equivalents 375.9 (25.8)
Cash and cash equivalents at beginning of period 1,191.3 1,200.9
Cash and cash equivalents at end of period $ 1,567.2 $ 1,175.1